Inhibition of Polo-Like Kinase 1 Promotes Hyperthermia Sensitivity via Inactivation of Heat Shock Transcription Factor 1 in Human Retinoblastoma Cells-Reference-Cited by-同舟云学术

Inhibition of Polo-Like Kinase 1 Promotes Hyperthermia Sensitivity via Inactivation of Heat Shock Transcription Factor 1 in Human Retinoblastoma Cells

Published:2013-12-23 Issue:13 Volume:54 Page:8353
ISSN:1552-5783
Container-title:Investigative Opthalmology & Visual Science
language:en
Short-container-title:Invest. Ophthalmol. Vis. Sci.

Author:

Yunoki Tatsuya¹,Tabuchi Yoshiaki²,Hayashi Atsushi³,Kondo Takashi⁴

Affiliation:

1. Department of Radiological Sciences, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan 2Department of Ophthalmology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan

2. Division of Molecular Genetics Research, Life Science Research Center, University of Toyama, Toyama, Japan

3. Department of Ophthalmology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan

4. Department of Radiological Sciences, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan

Publisher

Association for Research in Vision and Ophthalmology (ARVO)

Subject

General Medicine

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drugging Hijacked Kinase Pathways in Pediatric Oncology: Opportunities and Current Scenario;Pharmaceutics;2023-02-16

2. Xanthatin Selectively Targets Retinoblastoma by Inhibiting the PLK1-Mediated Cell Cycle;Investigative Opthalmology & Visual Science;2021-12-13

3. Aurora Kinase B Expression, Its Regulation and Therapeutic Targeting in Human Retinoblastoma;Investigative Opthalmology & Visual Science;2021-03-11

4. Inhibiting Heat Shock Factor 1 in Cancer: A Unique Therapeutic Opportunity;Trends in Pharmacological Sciences;2019-12

5. Injectable and Quadruple-Functional Hydrogel as an Alternative to Intravenous Delivery for Enhanced Tumor Targeting;ACS Applied Materials & Interfaces;2019-09-02